Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Rangering i aksjer #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Aksjekurs
$0.05207079
Sist synkronisert: 2023-11-15
Markedsverdi
$3.38M
Endring (1 dag)
0.13%
Endring (1 år)
0.00%
Land
AU
Handel Kazia Therapeutics Limited (KZA)

Kategori

Aksjeprishistorikk for Kazia Therapeutics Limited (KZA)
Høyeste sluttskurs: $0.05 den 2023-11-01

Laveste sluttskurs: $2.34 den 1994-09-01
Aksjeprishistorikk for Kazia Therapeutics Limited fra 1994 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 -14.41%
2022 -93.21%
2021 -12.26%
2020 134.56%
2019 60.49%
2018 -10.55%
2017 -54.36%
2016 -26.11%
2015 4.87%
2014 -53.60%
2013 40.89%
2012 29.78%
2011 -12.03%
2010 -76.36%
2009 -1.22%
2008 -56.70%
2007 -44.36%
2006 -47.25%
2005 -15.26%
2004 -19.24%
2003 269.42%
2002 32.67%
2001 -37.00%
2000 -7.16%
1999 14.60%
1998 11.28%
1997 0.36%
1996 133.15%
1995 54.37%
1994 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE